The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development

The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development

Peroxisome proliferator-activated receptors (PPARs) are a well-known pharmacological target for the treatment of multiple diseases, including diabetes mellitus, dyslipidemia, cardiovascular diseases and even primary biliary cholangitis, gout, cancer, Alzheimer’s disease and ulcerative coli...

Full description

Bibliographic Details
Main Authors: Fan Hong, Pengfei Xu, Yonggong Zhai
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:International Journal of Molecular Sciences
Subjects:
PPAR
ligand
T2DM
dyslipidemia
TZDs
Online Access:http://www.mdpi.com/1422-0067/19/8/2189

Internet

http://www.mdpi.com/1422-0067/19/8/2189

Similar Items